Thierry Petit
5PUBLICATIONS
50CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 03, 2025
18F-Fluorodeoxyglucose PET-CT evaluation after one course of neoadjuvant therapy fails to predict pCR in HER2 + BC patients: a prospective and multicentric French study.M Chanchou, M A Mouret-Reynier, I Molnar
|Sep 09, 2024
Long-term behavioral symptom clusters among survivors of early-stage breast cancer: Development and validation of a predictive model.Martina Pagliuca, Julie Havas, Emilie Thomas
|Aug 06, 2024
Metabolomic Prediction of Breast Cancer Treatment-Induced Neurologic and Metabolic Toxicities.Max Piffoux, Jérémie Jacquemin, Mélanie Pétéra
|May 11, 2024
Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer: Real-life data from the temporary use authorization program in France.Thierry Petit, Nawale Hajjaji, Eric-Charles Antoine
|Jan 07, 2021
Adjuvant Trastuzumab Is Required in Human Epidermal Growth Factor Receptor 2-Positive Node-Negative Breast Cancer Patients Regardless of Tumour Size.Laura Bender, Jean-Emmanuel Kurtz, Thierry Petit
Pageof 1
Frequent Collaborators
2 joint publications
Olivier Trédan
2 joint publications
Olivier Rigal
2 joint publications
Julie Havas
2 joint publications
Mario Campone
2 joint publications
Barbara Pistilli
1 joint publications
I Molnar
1 joint publications
E Deshayes
1 joint publications
Antonio Di Meglio
1 joint publications
S Bardet
1 joint publications
C Levy
